Board of Gland Pharma approves change in directorate
At meeting held on 10 March 2022
The Board of Gland Pharma at its meeting held on 10 March 2022 has approved the appointment of Yao Fang (DIN: 09524705) as an Additional Director, categorized as Non Independent and Non-Executive Director, with effect from 10 March 2022. The Board also accepted the resignation of Li Dongming (DIN: 08047543) with effect from the conclusion of Board Meeting on 10 March 2022.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content